AstraZeneca PLC Stock Performance
as on May 14, 2026 at 4:13 am IST
Day's Low
Day's High
$183.36$186.37
1.39%
Downside
0.23%
Upside
52 Week's Low
52 Week's High
$66.16$212.7164.42%
Downside
14.39%
Upside
AstraZeneca PLC share price movements today
- Previous Close
- $184.54
- Open
- $183.39
- Volume
- 654.6K
- Day's Low - High
- $183.36 - $186.37
- 52 Week Low - High
- $66.16 - $212.71
AstraZeneca PLC Historical Returns
- 1 Month Return
- -8.75 %
- 3 Month Return
- -10.22 %
- 1 Year Return
- + 172.5 %
- 3 Year Return
- + 146.94 %
- 5 Year Return
- + 235.22 %
AstraZeneca PLC Stock Fundamentals & Key Indicators
Check AstraZeneca PLC market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$282.0B
EPS (TTM)
5.1505
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.05%
PE Ratio (TTM)
27.39
Industry PE ratio
21.26875
PEG Ratio
1.5217
EBITDA
20.0B
Revenue (TTM)
60.4B
Profit Margin
17.19%
Return On Equity TTM
23.48%
AstraZeneca PLC Stock Valuation
Track how AstraZeneca PLC P/E has moved over time to understand its valuation trends.
AstraZeneca PLC in the last 5 years
Lowest (-90.30x)
March 31, 2022
Industry (21.27x)
May 13, 2026
Today (27.39x)
May 13, 2026
Highest (48.58x)
September 30, 2022
Today’s Price to Earnings Ratio: 27.39x
AstraZeneca PLC vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of AstraZeneca PLC with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $282.0B | 235.22% | 27.39 | 17.19% | |
| BUY | $862.3B | 407.78% | 34.33 | 34.99% | |
| BUY | $358.3B | 78.27% | 99.4 | 5.79% | |
| BUY | $533.0B | 31.95% | 25.63 | 21.83% | |
| BUY | $274.8B | 42.8% | 31.35 | 13.59% |
Stock Returns calculator for AstraZeneca PLC Stock including INR - Dollar returns
The AstraZeneca PLC stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
AstraZeneca PLC investment value today
Current value as on today
₹3,08,173
Returns
₹2,08,173
(+208.17%)
Returns from AstraZeneca PLC Stock
₹1,74,587 (+174.59%)
Dollar Impact
₹33,587 (+33.59%)
Analyst Recommendation on AstraZeneca PLC Stock
Based on 38 analysts
81.58%
Buy
15.79%
Hold
2.63%
Sell
Based on 38 analysts, 81.58% of analysts recommend a 'BUY' rating for AstraZeneca PLC. Average target price of $223.79
AstraZeneca PLC Share Price Target
Get share price movements and forecasts by analysts on AstraZeneca PLC.
What analysts predicted
16.91%UPSIDE
Target Price
$223.79
Current Price
$185.95
Analyzed by
38 Analysts
Target
$223.79
AstraZeneca PLC target price $223.79, a slight upside of 16.91% compared to current price of $185.95. According to 38 analysts rating.
Indian Investors' Interest in AstraZeneca PLC Stock
Investment in AstraZeneca PLC Shares on INDmoney has grown by 31.64% in the last 30 days, indicating increased investment activity.
Time period: to
Change:31.64% versus previous 30 day period
Search interest for AstraZeneca PLC Stock has increased by 38% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:38% versus previous 30 day period
AstraZeneca PLC Quarterly Profit & Loss
All numbers in Millions USD
AstraZeneca PLC Annual Profit & Loss
All numbers in Millions USD
AstraZeneca PLC Quarterly Cash Flow
All numbers in Millions USD
AstraZeneca PLC Annual Cash Flow
All numbers in Millions USD
AstraZeneca PLC News & Key Events
Today's Timeline - 04 May
Mon, 10:01 AM
-FDA advisory panel gives mixed votes on AstraZeneca's oncology drugs, impacting future regulatory strategies.
Mon, 06:24 PM
-AstraZeneca reports strong Q4 results and raises 2026 revenue guidance, indicating continued growth potential.
Insights on AstraZeneca PLC
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
AstraZeneca PLC has shown positive profit trends over the last two quarters. The company's net profit increased from $2.32 billion to $3.08 billion, reflecting an average quarterly growth of 24.5%.
- POSITIVE IMPACT
Price Rise
In the last 6 months, AZN stock has moved up by 108.3%
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, AZN has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, AZN has outperformed top 5 stocks with highest market-cap in its industry
NEGATIVE IMPACTRevenue Fall
AstraZeneca PLC has experienced a decline in revenue over the last two quarters. The revenue decreased from $15.50 billion to $15.28 billion, representing an average decrease of 1.4% per quarter.
About AstraZeneca PLC
| Organisation | AstraZeneca PLC |
| Headquarters | 1 Francis Crick Avenue, Cambridge, United Kingdom, CB2 0AA |
| Industry | Drug Manufacturers - General |
| CEO | Mr. Pascal Claude Roland Soriot D.V.M., M.B.A. |
| E-voting on shares | Click here to vote |
Key Management of AstraZeneca PLC
Name | Title |
|---|---|
Mr. Pascal Claude Roland Soriot D.V.M., M.B.A. | CEO & Executive Director |
Ms. Iskra Reic | Executive Vice President of International |
Mr. David Fredrickson | Executive Vice-President of Oncology Haematology Business Unit |
Ms. Ruth March FMEDSCI, O.B.E., Ph.D. | Senior VP of Precision Medicine - R&D Oncology |
Dr. Aradhana Sarin M.D. | CFO & Executive Director |
Ms. Pam P. Cheng | EVP of Global opt. & IT, Chief Sust. Officer and Member of External Sust.Adv. Board |
Mr. Joris Silon | Head of Investor Relations |
Mr. Jeffrey Pott J.D. | CHRO, Chief Compliance Officer, General Counsel & Member of External Sustainability Advisory Board |
Dr. Ruud Dobber Ph.D. | Executive Vice-President of BioPharmaceuticals Business Unit |
Dr. Susan Mary Galbraith M.D., Ph.D. | Executive Vice President of Oncology R&D |
FAQs
What is AstraZeneca PLC share price today?
AstraZeneca PLC share price today is $185.95 as on . AstraZeneca PLC share today touched a day high of $186.37 and a low of $183.36.
What is the 52 week high and 52 week low for AstraZeneca PLC share?
AstraZeneca PLC share touched a 52 week high of $212.71 on and a 52 week low of $66.16 on . AstraZeneca PLC stock price today i.e. is trending at $185.95,which is 12.58% down from its 52 week high and 181.06% up from its 52 week low.
What is AstraZeneca PLC's market capitalisation today?
AstraZeneca PLC market capitalisation is $0.28T as on .
How to invest in AstraZeneca PLC Stock (AZN) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for AstraZeneca PLC on INDmoney app. Click on Buy button. You can invest as low as $1.5 in AstraZeneca PLC Shares that will get you 0.0081 shares as per AstraZeneca PLC share price of $185.95 per share as on May 13, 2026 at 10:43 pm IST.
What is the minimum amount required to buy AstraZeneca PLC Stock (AZN) from India?
Indian investors can start investing in AstraZeneca PLC (AZN) shares with as little as ₹95.705 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in AstraZeneca PLC stock (as per the Rupee-Dollar exchange rate as on ).
Based on AstraZeneca PLC share’s latest price of $185.95 as on May 13, 2026 at 10:43 pm IST, you will get 0.0538 shares of AstraZeneca PLC. Learn more about
fractional shares .
What are the returns that AstraZeneca PLC has given to Indian investors in the last 5 years?
AstraZeneca PLC stock has given 235.22% share price returns and 29.72% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?